Skip to main content
. 2018 Feb 23;62(3):e01215-17. doi: 10.1128/AAC.01215-17

TABLE 2.

Clinical information and molecular characteristics of selected CRAB isolates with blaOXA-23-like or blaOXA-24-like

Characteristic No. (%) of CRAB isolates with:
blaOXA-23-like blaOXA-24-like Overall
Total 60 22 82
Period of isolation
    Before 2006 2 (3.3) 5 (22.7) 7 (8.5)
    2008 27 (45) 7 (31.8) 34 (41.5)
    2010 31 (51.7) 10 (45.5) 41 (50)
Hospital level
    Medical center 19 (31.7) 9 (40.9) 28 (34.1)
    Regional hospital 41 (68.3) 13 (59.1) 54 (65.9)
Region of Taiwan
    Eastern 0 (0) 4 (18.2) 4 (4.9)
    Central 44 (73.3) 0 (0) 44 (53.7)
    Northern 16 (26.7) 1 (4.5) 17 (20.7)
    Southern 0 (0) 17 (77.3) 17 (20.7)
Specimen source
    Respiratory 41 (68.3) 12 (54.5) 53 (64.6)
    Pus/discharge 6 (10) 5 (22.7) 11 (13.4)
    Blood 4 (6.7) 1 (4.5) 5 (6.1)
    Urine 7 (11.7) 2 (9.1) 9 (11)
    Others 2 (3.3) 2 (9.1) 4 (4.9)
Patient age group
    Adult 12 (20) 7 (31.8) 19 (23.2)
    Elderly 42 (70) 13 (59.1) 55 (67.1)
    Pediatric 1 (1.7) 2 (9.1) 3 (3.7)
    Unknown 5 (8.3) 0 (0) 5 (6.1)
Presence of other resistance genes
    armA 55 (91.7) 21 (95.5) 76 (92.7)
    aphA1 52 (86.7) 20 (90.9) 72 (87.8)
    aphA6 3 (5) 1 (4.5) 4 (4.9)
    aacC1 48 (80) 20 (90.9) 68 (82.9)
    aacA4 54 (90) 20 (90.9) 74 (90.2)
    aadB 0 (0) 3 (13.6) 3 (3.7)
    aadA1 58 (96.7) 21 (95.5) 79 (96.3)
    blaTEM 28 (46.7) 10 (45.5) 38 (46.3)
    ISAba1-ampC 34 (56.7) 16 (72.7) 50 (61)
    blaSHV 0 (0) 0 (0) 0 (0)
    blaPER 0 (0) 0 (0) 0 (0)